Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diclophenac Potassium Versus Ceftazidime for Reduction of Post ERCP Pancreatitis in Average Risk Patients-double Blind, Randomised Controlled Trial

NCT01784445 is registered in ClinicalTrials.gov with University Hospital Rijeka as lead sponsor.

NCT NCT01784445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01784445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diclophenac Potassium Versus Ceftazidime for Reduction of Post ERCP Pancreatitis in Average Risk Patients-double Blind, Randomised Controlled Trial
Lead sponsor
University Hospital Rijeka
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2013
Completion date
February 28, 2015
Enrollment
124 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatitis